Logo image of ZVO

ZOVIO INC (ZVO) Stock Fundamental Analysis

NASDAQ:ZVO - Nasdaq - US98979V1026 - Common Stock - Currency: USD

0.0928  -0.03 (-22.67%)

After market: 0.085 -0.01 (-8.41%)

Fundamental Rating

1

Taking everything into account, ZVO scores 1 out of 10 in our fundamental rating. ZVO was compared to 71 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of ZVO have multiple concerns. ZVO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZVO has reported negative net income.
In the past year ZVO has reported a negative cash flow from operations.
ZVO Yearly Net Income VS EBIT VS OCF VS FCFZVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -47.91%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZVO Yearly ROA, ROE, ROICZVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150 -200

1.3 Margins

Industry RankSector Rank
OM -13.52%
PM (TTM) -17.8%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZVO Yearly Profit, Operating, Gross MarginsZVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

ZVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZVO has more shares outstanding than it did 1 year ago.
ZVO has a better debt/assets ratio than last year.
ZVO Yearly Shares OutstandingZVO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
ZVO Yearly Total Debt VS Total AssetsZVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

2.2 Solvency

ZVO has an Altman-Z score of 5.94. This indicates that ZVO is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.42 indicates that ZVO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 5.94
ROIC/WACCN/A
WACC5.6%
ZVO Yearly LT Debt VS Equity VS FCFZVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

ZVO has a Current Ratio of 0.95. This is a bad value and indicates that ZVO is not financially healthy enough and could expect problems in meeting its short term obligations.
ZVO has a Quick Ratio of 0.95. This is a bad value and indicates that ZVO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ZVO Yearly Current Assets VS Current LiabilitesZVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

1

3. Growth

3.1 Past

ZVO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -280.77%.
ZVO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.63%.
ZVO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.86% yearly.
EPS 1Y (TTM)-280.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.22%
Revenue 1Y (TTM)-32.63%
Revenue growth 3Y-15.98%
Revenue growth 5Y-12.86%
Sales Q2Q%-25.74%

3.2 Future

ZVO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.15% yearly.
ZVO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.00% yearly.
EPS Next Y41.98%
EPS Next 2Y39.12%
EPS Next 3Y23.7%
EPS Next 5Y16.15%
Revenue Next Year-11.5%
Revenue Next 2Y-3.93%
Revenue Next 3Y-4.14%
Revenue Next 5Y-4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZVO Yearly Revenue VS EstimatesZVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
ZVO Yearly EPS VS EstimatesZVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVO. In the last year negative earnings were reported.
Also next year ZVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZVO Price Earnings VS Forward Price EarningsZVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.66
ZVO Per share dataZVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ZVO's earnings are expected to grow with 23.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.12%
EPS Next 3Y23.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZVO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZOVIO INC

NASDAQ:ZVO (11/9/2022, 8:00:02 PM)

After market: 0.085 -0.01 (-8.41%)

0.0928

-0.03 (-22.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-01 2022-08-01
Earnings (Next)11-29 2022-11-29/amc
Inst Owners0.14%
Inst Owner Change-100%
Ins Owners5.52%
Ins Owner Change0%
Market Cap3.18M
Analysts40
Price Target5.1 (5395.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB N/A
EV/EBITDA 0.66
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.65
OCFYN/A
SpS6.72
BVpS0.19
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.91%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -13.52%
PM (TTM) -17.8%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover2.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.17%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 5.94
F-Score1
WACC5.6%
ROIC/WACCN/A
Cap/Depr(3y)304.95%
Cap/Depr(5y)202.03%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.22%
EPS Next Y41.98%
EPS Next 2Y39.12%
EPS Next 3Y23.7%
EPS Next 5Y16.15%
Revenue 1Y (TTM)-32.63%
Revenue growth 3Y-15.98%
Revenue growth 5Y-12.86%
Sales Q2Q%-25.74%
Revenue Next Year-11.5%
Revenue Next 2Y-3.93%
Revenue Next 3Y-4.14%
Revenue Next 5Y-4%
EBIT growth 1Y53.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.53%
EBIT Next 3Y29.79%
EBIT Next 5Y20.84%
FCF growth 1Y-77.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-225.78%
OCF growth 3YN/A
OCF growth 5YN/A